Is there a Gavi programme to support the introduction of this vaccine? If a Gavi programme is available, what support is available to countries?
Gavi supports PCV introduction since 2009 with use of Pneumococcal Advance Market Commitment up to 2020. Contracts with manufacturers continue through 2029. Gavi provides support for routine introduction and catch-up introduction funding PCVs and injection supplies and vaccine introduction grants. Go to footnote 1
Sources
- Go back to footnote reference 1
Gavi, the Vaccine Alliance (2022). Vaccine Funding Guidelines. Gavi, the Vaccine Alliance. Available at: https://www.gavi.org/sites/default/files/document/2022/Vaccine_FundingGuidelines_0.pdf (accessed 5 August 2025.